Applied DNA Sciences Inc APDN:NASDAQ

Last Price$3.70NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.68 (1)
Ask (Size)$3.69 (1)
Day Low / HighN/A - N/A
Volume556.1 K
 

View Biotechnology IndustryPeer Comparison as of 01/21/2022

 

Applied DNA Sciences Inc ( NASDAQ )

Price: $3.70
Change: -0.21 (5.37%)
Volume: 556.1 K
4:00PM ET 1/21/2022
 
 

NXT-ID Inc ( NASDAQ )

Price: $3.03
Change: -0.13 (4.11%)
Volume: 932.1 K
4:00PM ET 1/21/2022
 
 

Evolving Systems Inc ( NASDAQ )

Price: $1.90
Change: -0.06 (3.06%)
Volume: 113.5 K
3:59PM ET 1/21/2022
 
 

SilverSun Technologies Inc ( NASDAQ )

Price: $3.89
Change: -0.20 (4.89%)
Volume: 33.3 K
3:59PM ET 1/21/2022
 
 

Xcel Brands Inc ( NASDAQ )

Price: $1.01
Change: -0.07 (6.48%)
Volume: 39.6 K
4:00PM ET 1/21/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Retreat This Afternoon
4:04PM ET 1/21/2022 MT Newswires

Health care stocks were ending mostly lower this afternoon, with the NYSE Health Care Index falling 0.9% and the SPDR Health Care Select Sector ETF (XLV)...

Sector Update: Health Care Stocks Drifting Lower in Friday Trade
1:07PM ET 1/21/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 0.4%, while the SPDR Health Care Select Sector ETF (XLV) was...

Applied DNA Unit Seeks US FDA Emergency Use Authorization for RT-PCR COVID-19 Test, Home Collection Kit
10:38AM ET 1/21/2022 MT Newswires

Applied DNA Sciences (APDN) said Friday its Applied DNA Clinical Labs unit filed a request with the US Food and Drug Administration for emergency use...

Applied DNA Sciences' COVID-19 Test Gets Conditional Approval in New York
9:52AM ET 1/04/2022 MT Newswires

Applied DNA Sciences Inc (APDN) said Tuesday the New York State Department of Health has given conditional approval to its unit Applied DNA Clinical Labs...

Company Profile

Business DescriptionApplied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. Its proprietary platform produces large quantities of DNA for use in nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets (Biotherapeutic Contract Research and Manufacturing) and for supply chain security, anti-counterfeiting and anti-theft technology purposes. The company was founded in 1983 and is headquartered in Stony Brook, NY. View company web site for more details
Address50 Health Sciences Drive
Stony Brook, New York 11790
Phone+1.631.240.8800
Number of Employees59
Recent SEC Filing01/13/2022SC 13G/A
Chairman, President & Chief Executive OfficerJames A. Hayward
Chief Operating OfficerJudy Murrah
Chief Financial Officer & ControllerBeth M. Jantzen
Vice President-Strategic SalesWayne Buchen

Company Highlights

Price Open$3.91
Previous Close$3.91
52 Week Range$3.60 - 13.64
Market Capitalization$27.7 M
Shares Outstanding7.5 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.93
Beta vs. S&P 500N/A
Revenue$3.9 M
Net Profit Margin-158.25%
Return on Equity-111.92%

Analyst Ratings as of 02/12/2021

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset